Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92.4M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
9.02M
-
Shares change
-
+201K
-
Total reported value, excl. options
-
$105M
-
Value change
-
+$2.57M
-
Number of buys
-
22
-
Number of sells
-
-8
-
Price
-
$11.62
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q2 2019
43 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q2 2019.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.02M shares
of 92.4M outstanding shares and own 9.75% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.41M shares), ORBIMED ADVISORS LLC (1.48M shares), Fosun International Ltd (794K shares), BlackRock Inc. (634K shares), FMR LLC (622K shares), KORNITZER CAPITAL MANAGEMENT INC /KS (483K shares), VANGUARD GROUP INC (457K shares), STATE STREET CORP (181K shares), Point72 Asset Management, L.P. (142K shares), and Asymmetry Capital Management, L.P. (133K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.